Carla Roberts-Toler1, Brian T O'Neill1, Aaron M Cypess1,2. 1. Section of Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA. 2. Translational Physiology Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA.
Abstract
OBJECTIVE: Diet-induced obesity (DIO) causes several pathophysiological changes in adipose tissue. Increased inflammation reduces white adipose tissue (WAT) insulin sensitivity and contributes to the development of diabetes. However, little is known about how DIO alters the function of brown adipose tissue (BAT), an organ that consumes calories by β3-adrenergic receptor (AR)-mediated thermogenesis and helps regulate energy balance. METHODS: To test the effects of DIO on BAT, we fed 6-week-old C57BL/6 mice either a normal chow diet (NCD) or a high-fat diet (HFD). After 16 additional weeks, we measured body fat, WAT, and BAT mRNA expression, glucose tolerance, and rates of glucose uptake in response to insulin and the β3-AR agonist mirabegron. RESULTS: Compared with NCD, HFD increased body fat and impaired glucose tolerance. Both WAT and BAT had higher mRNA levels of markers of inflammation, including TNFα and F4/80. Insulin signaling in BAT and WAT was reduced, with decreased Akt phosphorylation. Diet-normalized BAT glucose uptake rates were lower in response to mirabegron. CONCLUSIONS: These results support a model in which DIO leads to BAT inflammation and insulin resistance, leading to a broader impairment of BAT function.
OBJECTIVE: Diet-induced obesity (DIO) causes several pathophysiological changes in adipose tissue. Increased inflammation reduces white adipose tissue (WAT) insulin sensitivity and contributes to the development of diabetes. However, little is known about how DIO alters the function of brown adipose tissue (BAT), an organ that consumes calories by β3-adrenergic receptor (AR)-mediated thermogenesis and helps regulate energy balance. METHODS: To test the effects of DIO on BAT, we fed 6-week-old C57BL/6 mice either a normal chow diet (NCD) or a high-fat diet (HFD). After 16 additional weeks, we measured body fat, WAT, and BAT mRNA expression, glucose tolerance, and rates of glucose uptake in response to insulin and the β3-AR agonist mirabegron. RESULTS: Compared with NCD, HFD increased body fat and impaired glucose tolerance. Both WAT and BAT had higher mRNA levels of markers of inflammation, including TNFα and F4/80. Insulin signaling in BAT and WAT was reduced, with decreased Akt phosphorylation. Diet-normalized BAT glucose uptake rates were lower in response to mirabegron. CONCLUSIONS: These results support a model in which DIO leads to BAT inflammation and insulin resistance, leading to a broader impairment of BAT function.
Authors: T Yamauchi; H Waki; J Kamon; K Murakami; K Motojima; K Komeda; H Miki; N Kubota; Y Terauchi; A Tsuchida; N Tsuboyama-Kasaoka; N Yamauchi; T Ide; W Hori; S Kato; M Fukayama; Y Akanuma; O Ezaki; A Itai; R Nagai; S Kimura; K Tobe; H Kagechika; K Shudo; T Kadowaki Journal: J Clin Invest Date: 2001-10 Impact factor: 14.808
Authors: Antti P M Viljanen; Patricia Iozzo; Ronald Borra; Mikko Kankaanpää; Anna Karmi; Riikka Lautamäki; Mikko Järvisalo; Riitta Parkkola; Tapani Rönnemaa; Letizia Guiducci; Terho Lehtimäki; Olli T Raitakari; Andrea Mari; Pirjo Nuutila Journal: J Clin Endocrinol Metab Date: 2008-10-28 Impact factor: 5.958
Authors: Wouter D van Marken Lichtenbelt; Joost W Vanhommerig; Nanda M Smulders; Jamie M A F L Drossaerts; Gerrit J Kemerink; Nicole D Bouvy; Patrick Schrauwen; G J Jaap Teule Journal: N Engl J Med Date: 2009-04-09 Impact factor: 91.245
Authors: Aaron M Cypess; Sanaz Lehman; Gethin Williams; Ilan Tal; Dean Rodman; Allison B Goldfine; Frank C Kuo; Edwin L Palmer; Yu-Hua Tseng; Alessandro Doria; Gerald M Kolodny; C Ronald Kahn Journal: N Engl J Med Date: 2009-04-09 Impact factor: 91.245
Authors: Swarup K Chakrabarti; Banumathi K Cole; Yeshao Wen; Susanna R Keller; Jerry L Nadler Journal: Obesity (Silver Spring) Date: 2009-06-11 Impact factor: 5.002
Authors: Marion Soto; Lucie Orliaguet; Michelle L Reyzer; M Lisa Manier; Richard M Caprioli; C Ronald Kahn Journal: Proc Natl Acad Sci U S A Date: 2018-01-08 Impact factor: 11.205
Authors: Jong In Kim; Jeu Park; Yul Ji; Kyuri Jo; Sang Mun Han; Jee Hyung Sohn; Kyung Cheul Shin; Ji Seul Han; Yong Geun Jeon; Hahn Nahmgoong; Kyung Hee Han; Jiwon Kim; Sun Kim; Sung Sik Choe; Jae Bum Kim Journal: Mol Cell Biol Date: 2019-09-27 Impact factor: 4.272
Authors: Nathan C Winn; Victoria J Vieira-Potter; Michelle L Gastecki; Rebecca J Welly; Rebecca J Scroggins; Terese M Zidon; T'Keaya L Gaines; Makenzie L Woodford; Natalia G Karasseva; Jill A Kanaley; Harold S Sacks; Jaume Padilla Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-11-23 Impact factor: 3.619
Authors: Alexander W Fischer; Kirstin Albers; Christian Schlein; Frederike Sass; Lucia M Krott; Hartwig Schmale; Philip L S M Gordts; Ludger Scheja; Joerg Heeren Journal: Biochim Biophys Acta Mol Basis Dis Date: 2019-03-21 Impact factor: 5.187
Authors: Jae Hyun Jung; Su Bin Hwang; Hyeon Ju Park; Guang-Ri Jin; Bog Hieu Lee Journal: Evid Based Complement Alternat Med Date: 2021-06-25 Impact factor: 2.629